CIK 0000885590
- Large accelerated filer
Bausch Health Companies Inc.
Sign in to watch- Ticker
- BHC
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- NJ
- Entity type
- Operating
- Phone
- +1 514-744-6792
- Business address
- 2150 ST. ELZEAR BLVD. WEST, LAVAL, QUEBEC, Quebec, Canada, H7L 4A8
- Former names
- Valeant Pharmaceuticals International, Inc., BIOVAIL Corp, BIOVAIL CORP INTERNATIONAL, BIOVAIL CORPORATION INTERNATIONAL
- 4/A Grant or award Chief Executive Officer acquired 519,328 shares (grant or award)
- 4/A Insider Changes in Ownership
- 4 Grant or award Director acquired 35,360 shares (grant or award)
- 4 Grant or award Director acquired 35,360 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Grant or award Director acquired 35,360 shares (grant or award)
- 4 Grant or award Director acquired 35,360 shares (grant or award)
- 4 Grant or award Director acquired 35,360 shares (grant or award)
- 4/A Grant or award Director acquired 35,360 shares (grant or award)
- 4 Grant or award Director acquired 35,360 shares (grant or award)
- 4 Grant or award Director acquired 35,360 shares (grant or award)
- 4 Grant or award Director acquired 35,360 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Grant or award Director acquired 5,890 shares (grant or award)
- 4 Grant or award Director acquired 3,122 shares (grant or award)
- 4 Grant or award Director acquired 2,945 shares (grant or award)
- 4 Grant or award Director acquired 647 shares (grant or award)
- 4 Shares withheld for taxes SVP, Controller & CAO gave up 3,188 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Executive Officer gave up 116,982 shares (to pay taxes)
- 4 Planned sale EVP, General Counsel sold 6,313 shares at $9.80 ($61,867)
Page 6 of 61 · 1,214 filings